Hepatoprotective Effect of the N-Alkylated Isobornylamine against CCl4-Induced Chronic Liver Damage in Mice †
Abstract
:Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pon`kina, D.; Kuranov, S.; Zhukova, N.; Meshkova, Y.; Khvostov, M.; Luzina, O.; Tolstikova, T.; Salakhutdinov, N. Hepatoprotective Effect of the N-Alkylated Isobornylamine against CCl4-Induced Chronic Liver Damage in Mice. Med. Sci. Forum 2022, 14, 1. https://doi.org/10.3390/ECMC2022-13152
Pon`kina D, Kuranov S, Zhukova N, Meshkova Y, Khvostov M, Luzina O, Tolstikova T, Salakhutdinov N. Hepatoprotective Effect of the N-Alkylated Isobornylamine against CCl4-Induced Chronic Liver Damage in Mice. Medical Sciences Forum. 2022; 14(1):1. https://doi.org/10.3390/ECMC2022-13152
Chicago/Turabian StylePon`kina, Darya, Sergey Kuranov, Nataliya Zhukova, Yulia Meshkova, Mikhail Khvostov, Olga Luzina, Tatyana Tolstikova, and Nariman Salakhutdinov. 2022. "Hepatoprotective Effect of the N-Alkylated Isobornylamine against CCl4-Induced Chronic Liver Damage in Mice" Medical Sciences Forum 14, no. 1: 1. https://doi.org/10.3390/ECMC2022-13152